Russia: Toxicity data required [Regulatives / Guidelines]

posted by mittyri  – Russia, 2013-09-02 16:18 (4678 d 04:40 ago) – Posting: # 11407
Views: 11,934

Hi Helmut & Karthikeyan!

Helmut knows (almost) everything ;-)

❝ ❝ i am in need of information, whether that is sufficient or we need additional toxicity or clinical trials...

❝ You need toxicity data of the formulations (test + reference!) – not only of the API – before you start a BE study.


At this moment - yes. I would pay your attention on new amends prepared by MoH and experts. They are going to be approved soon.
According to this draft it will be allowed only to post a literature review of originator's preclinical trials.
It's discussed now about data exclusivity of this data. May be it would be possible only with originator's permision (or 6 years after Originator's registration)

No one knows how would it works :confused:

❝ Anyhow, according to federal law #61 (aka “Lex Putin”)

:-D

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
127 visitors (0 registered, 127 guests [including 27 identified bots]).
Forum time: 20:59 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5